The CREBBP Acetyltransferase Is a Haploinsufficient Tumor Suppressor in B-cell Lymphoma
Year: 2017
Type: article
Abstract: Inactivating mutations of the CREBBP acetyltransferase are highly frequent in diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL), the two most common germinal center (GC)–derived cancers. However, the role of CREBBP inactivation in lymphomagenesis remains unclear. Here, we show that CREBBP regulates enhancer/super-enhancer networks with central roles in GC/post-GC cell fate decisions, including genes involved in signal transduction by the B-cell receptor and CD40 receptor, transcriptional control of GC and plasma cell development, and antigen presentation. Consistently, Crebbp-deficient B cells exhibit enhanced response to mitogenic stimuli and perturbed plasma cell differentiation. Although GC-specific loss of Crebbp was insufficient to initiate malignant transformation, compound Crebbp-haploinsufficient/BCL2-transgenic mice, mimicking the genetics of FL and DLBCL, develop clonal lymphomas recapitulating the features of the human diseases. These findings establish CREBBP as a haploinsufficient tumor-suppressor gene in GC B cells and provide insights into the mechanisms by which its loss contributes to lymphomagenesis. Significance: Loss-of-function mutations of CREBBP are common and early lesions in FL and DLBCL, suggesting a prominent role in lymphoma initiation. Our studies identify the cellular program by which reduced CREBBP dosage facilitates malignant transformation, and have direct implications for targeted lymphoma therapy based on drugs affecting CREBBP-mediated chromatin acetylation. Cancer Discov; 7(3); 322–37. ©2017 AACR. This article is highlighted in the In This Issue feature, p. 235
Source: Cancer Discovery
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Keywords: CREB-binding protein, histone acetyltransferase, haploinsufficiency, tumor suppressor, B-cell lymphoma, diffuse large B-cell lymphoma, follicular lymphoma, germinal center B cells, super-enhancers, enhancer networks, plasma cell differentiation, B cell receptor signaling, CD40 signaling, antigen presentation, lymphomagenesis, chromatin acetylation
Open Access status: green
Funder: National Cancer Institute
Awards: Role of KMT2D Gene Inactivation in B cell Non Hodgkin Lymphoma, MSK SPORE in Lymphoma, Role of acetyltransferase gene inactivation in follicular lymphoma pathogenesis, The coding genome of HIV-associated plasmablastic lymphomas in South Africa, From pathogenesis to new therapeutic targets in diffuse large B cell lymphoma
OpenAlex ID: W2569993732
